Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.99
-0.38 (-1.56%)
At close: Sep 11, 2026, 4:00 PM EDT
24.10
+0.11 (0.46%)
After-hours: Sep 11, 2026, 7:59 PM EDT
Beam Therapeutics Employees
Beam Therapeutics had 540 employees as of June 30, 2026. The number of employees increased by 31 or 6.09% compared to the same quarter last year.
Employees
540
Change
31
Growth
6.09%
Revenue / Employee
$288,954
Profits / Employee
-$160,222
Market Cap
2.40B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 540 | 31 | 6.09% |
| Mar 31, 2026 | 522 | 129 | 32.82% |
| Dec 31, 2025 | 511 | 28 | 5.80% |
| Sep 30, 2025 | 510 | 38 | 8.05% |
| Jun 30, 2025 | 509 | 48 | 10.41% |
| Mar 31, 2025 | 393 | 47 | 13.58% |
| Dec 31, 2024 | 483 | 47 | 10.78% |
| Sep 30, 2024 | 472 | 33 | 7.52% |
| Jun 30, 2024 | 461 | -71 | -13.35% |
| Mar 31, 2024 | 346 | -177 | -33.84% |
| Dec 31, 2023 | 436 | -71 | -14.00% |
| Sep 30, 2023 | 439 | -68 | -13.41% |
| Jun 30, 2023 | 532 | 56 | 11.76% |
| Mar 31, 2023 | 523 | 129 | 32.74% |
| Dec 31, 2022 | 507 | 166 | 48.68% |
| Sep 30, 2022 | 507 | 201 | 65.69% |
| Jun 30, 2022 | 476 | 210 | 78.95% |
| Mar 31, 2022 | 394 | 178 | 82.41% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vera Therapeutics | 361 |
| Ocular Therapeutix | 325 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
| Pharvaris | 148 |
BEAM News
- 2 days ago - Beam Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 days ago - Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today - TheFly
- 2 days ago - Beam Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 3 days ago - Beam Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 3 days ago - Beam Therapeutics falls -12.4% - TheFly
- 3 days ago - Beam Therapeutics falls -12.7% - TheFly
- 4 days ago - Beam Therapeutics Transcript: Status update - Transcripts
- 4 days ago - Beam Therapeutics Press release: Status update - Filings